Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
Stephen R. Welch(Centers for Disease Control and Prevention), Christina F. Spiropoulou(Centers for Disease Control and Prevention)
Cited by 32
Related Papers
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
|Nature Communications|2019|74
Rift Valley Fever Virus Encephalitis Is Associated with an Ineffective Systemic Immune Response and Activated T Cell Infiltration into the CNS in an Immunocompetent Mouse Model
|PLoS neglected tropical diseases|2014|62
A public, cross‐reactive glycoprotein epitope confounds Ebola virus serology
|Journal of Medical Virology|2024|3